These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6803705)

  • 1. [Reproducibility of ventricular arrhythmias induced before and after drug therapy. Predictive value of their anti-arrhythmic effect].
    Frank R; Fontaine G; Coutte R; Tonet J; Cohen A; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():79-86. PubMed ID: 6803705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sustained ventricular tachycardia: epidemiological, clinical and prognostic aspects. Long-term follow up of different subgroups of patients under anti-arrhythmia therapy. I].
    Naccarella F; Palmieri M; Nanni G; Barbato G; Casella G; Bartoletti A; Bracchetti D
    Cardiologia; 1987 Jan; 32(1):55-64. PubMed ID: 3581116
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
    Breithardt G; Borggrefe M; Yeh HL; Seipel L
    Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug prevention and therapy of ventricular tachycardia].
    Burckhardt D; Hoffmann A
    Ther Umsch; 1992 Aug; 49(8):543-9. PubMed ID: 1519183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Programmed ventricular stimulation in detecting malignant ventricular arrhythmia following myocardial infarct].
    Klein H
    Internist (Berl); 1987 Mar; 28(3):151-8. PubMed ID: 3294721
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical electrophysiology of ventricular tachycardia.
    Prystowsky EN; Heger JJ; Lloyd EA; Zipes DP
    Cardiol Clin; 1983 May; 1(2):253-73. PubMed ID: 6544638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of tachycardic ventricular arrhythmias].
    Höpp HW; Kochs M; Hilger HH
    Med Klin (Munich); 1988 Nov; 83(23):800-8. PubMed ID: 3062347
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of serious cardiac arrhythmias with drugs.
    Echt DS; Mason JW
    Cardiovasc Clin; 1984; 14(3):191-209. PubMed ID: 6426796
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methods of detecting and monitoring ventricular excitability in coronary patients. Electric provocation of ventricular tachycardia and late ventricular potentials].
    Fauchier JP; Cosnay P; Rouesnel P; Dubois AM; Huguet R; Roux S
    Arch Mal Coeur Vaiss; 1986 Aug; 79(9):1348-55. PubMed ID: 3101639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Irreducible ventricular tachycardia: treatment by electrocoagulation after localization of the focus].
    Petitier H; Polu JM; Dodinot B; Sommelet P; Mathieu P; Faivre G
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):331-51. PubMed ID: 4995982
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic value of ventricular arrhythmias].
    Vergara G
    Ital Heart J Suppl; 2001 Dec; 2(12):1291-5. PubMed ID: 11838350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis and management of patients with tachycardial heart arrhythmia ].
    Steinbach K
    Wien Med Wochenschr; 1984 Oct; 134(19-20):425-6. PubMed ID: 6516418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The variability and prognostic significance of ventricular hyperkinetic arrhythmias in the postinfarct: the considerations after the CAST. Cardiac Arrhythmia Suppression Trial].
    Furlanello F; Gramegna L
    G Ital Cardiol; 1990 Jul; 20(7):615-7. PubMed ID: 2245899
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of prophylactic antiarrhythmic treatment on the incidence of ventricular arrhythmias in the postinfarction period (author's transl)].
    Wolf R; Sinn R; Guillen R
    Z Kardiol; 1982 Jan; 71(1):26-30. PubMed ID: 6175118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ventricular arrhythmias: diagnosis and drug therapy].
    Schüpfer C; Gertsch M
    Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of anti-arrhythmia agents. Their predictive value of therapeutic effects].
    Lévy S
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():29-35. PubMed ID: 6803700
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of acute ventricular tachycardia or fibrillation.
    Dorian P; Philippon F
    Can J Cardiol; 2000 Jun; 16 Suppl C():16C-9C. PubMed ID: 10887272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.